Navigation Links
Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference
Date:3/5/2008

-Multimedia Capabilities of the Dynamic LearnSpace, Such as eLocker, Chat

and Online Testing, To Be Showcased -

MENLO PARK, Calif., March 5 /PRNewswire/ -- Studywiz Spark, the first and only Dynamic LearnSpace for K-12 education, will be presented by Southgate Community Schools at the 2008 Michigan Association for Computer Users in Learning (MACUL) Conference, March 5-7, at the Amway Grand Plaza Hotel and DeVos Place Convention Center. The multimedia capabilities of Studywiz Spark that enable 21st Century learning will be introduced to conference attendees during a one-hour session from 4:00pm-5:00pm on March 6, Room Emerald B, on the Concourse Level of the Amway Grand Plaza Hotel. The session is entitled "eCampus, A Virtual Learning Environment for K-12: Bringing 21st Century Tools Into the Classroom."

"Studywiz Spark is an advanced communication tool that allows group collaboration, individual personalization and engagement of students," said Bob Longo, Executive Vice President, Studywiz Spark. "The Dynamic LearnSpace enables schools like Southgate to access multimedia capabilities, like collaborative galleries, eLocker, messaging, chat and online testing that help to improve communication between teachers, students and even parents."

"Southgate selected Studywiz Spark as the technology platform that would enable our teachers to optimize instructional materials and share curricula and rich-media content across the district, particularly in our elementary schools," said Mike Toschi, Southgate Director of Technology. "We have six elementary buildings that house 130 instructors, who are teaching the same content, and we needed a system that would allow for group collaboration and communication among our teachers and students."

During MACUL, Southgate will present a firsthand account of its experience with Studywiz Spark and how its teachers and students are using the multimedia applications to engage in 21st Centur
'/>"/>

SOURCE Studywiz Spark
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Syndicom to Launch Online Community for DePuy Spine
3. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
4. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
5. American Diabetes Association and Goya Foods Inc. Team Up To Support Diabetes Awareness and Outreach in the Latino Community
6. Optim To Assist Prairie Community Health Center with Construction Scope Development
7. Uninsured community health center patients often have difficulty accessing specialty services
8. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
9. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
10. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan
11. Free Diabetes Community Health Worker Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- ... (MTF) -- the largest survey on teen drug abuse ... underscores that teens, intentional abuse of prescription (Rx) and ... concern, with an alarming number of young people abusing ... Teen Abuse of Medication Continues to Be ...
(Date:12/14/2009)... SANTA ANA, Calif., Dec. 14 Grubb & Ellis ... directors has authorized a daily distribution to stockholders of record ... the period commencing on Jan. 1, 2010 and ending on ... on 365 days in the calendar year and will be ... a purchase price of $10.00 per share. These distributions ...
(Date:12/14/2009)... On December 9, 2009, the United States ... position that private insurance companies are "plans" and therefore ... other federal courts have held that contracts issued by ... Title 18 Section 1347, US vs. Frost ... been held to be a "plan," because, as the ...
(Date:12/14/2009)... hadn,t spread, study finds , , MONDAY, Dec. 14 (HealthDay ... death in male colon cancer survivors, researchers report. , ... men who,d been treated for stage I, stage II ... (nonmetastatic cancer). Every two years, the men were sent ... disease diagnoses, as well as their physical activity. A ...
(Date:12/14/2009)... shouldn,t worry most users, researcher says , , MONDAY, Dec. ... may have a small but statistically significant increased risk ... the medications, a new study finds. , "But statistical ... Jordan W. Smoller, an associate professor of psychiatry at ... in the Dec. 14 issue of Archives of ...
Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:Insurance Now Subject to Federal Jurisdiction 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3
... New Study in the Journal of Cosmetic Dermatology Finds Over-the-Counter ... for Helping to Clear Up Mild to Moderate EczemaEDISON, N.J., ... looking for a cost-effective way to control and heal this ... to consider. A new study in the March 2009 issue ...
... Surge in anxiety-linked hormone worsens blood sugar level, researchers suggest ... a key role in the development of type 2 diabetes ... has been given to the role of obesity in the ... important in this at-risk population," study co-author Anastasia Georgiades, of ...
... Inc. (NYSE: MED ) announced today that it ... for the period ended December 31, 2008 on Thursday, March ... Company will hold a conference call and web cast to ... a.m. ET.Interested parties can access the call by dialing (877) ...
... Minn., March 5 People across the country are now ... from Upsher-Smith Laboratories, Inc. AmLactin(R) Foot Cream Therapy provides ... dry and chapped feet because of its high concentration of ... Dry, chapped feet are the result of various factors ...
... Susan Dell Foundation awards grant totaling more than $3 ... -AUSTIN, Texas, March 5 The Michael & Susan ... The University of Texas School of Public ... expansion of the Coordinated Approach To Child Health (CATCH) ...
... Approvals for Intravenous Formulation of Temozolomide As Well As ... 5 Schering-Plough Corporation (NYSE: SGP ) ... FDA both approved the intravenous (IV) formulation of temozolomide ... of the drug. Temozolomide is marketed as TEMODAL(R) ...
Other Medicine News:Health News:Commonly Used Beauty Staple Clinically Proven to Help Treat Eczema 2Health News:Commonly Used Beauty Staple Clinically Proven to Help Treat Eczema 3Health News:Stress May Raise Diabetes Risk for Obese Black Women 2Health News:Medifast, Inc. to Announce Fourth Quarter and Fiscal Year 2008 Financial Results on Thursday, March 12, 2009 2Health News:New AmLactin(R) Foot Cream Immerses Feet in Moisture 2Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 2Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 3Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 4Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 3Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 4Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 5Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 6Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 7
(Date:12/14/2009)... -- Travelers of Interstate 70 west of Indianapolis will ... more colorful when 10 multicolored art forms are installed ... going home , will eventually include 34 total pieces ... at Herron School of Art and Design, through the ... ,, Eli Lilly and Company (NYSE: LLY ...
(Date:12/14/2009)... Pa., Dec. 14 CPG International, ... engineered building products, introduces VYCOM, a rebranded ... the previous VYCOM Corporation and Scranton Products ... wholly recognized business unit within CPG International, ... Products Commercial. The VYCOM business unit has ...
(Date:12/14/2009)... Pharmaceutical Inc. (OTC Bulletin Board: OHRP) announced today ... in Irvine, CA, with offices also in New ... relations and corporate communications. Ohr Pharmaceutical is ... advanced drugs for underserved therapeutic needs. The Company ... markets: OHR/AVR118 for the treatment of Cachexia and ...
Breaking Medicine Technology:Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3Milwaukee Employers See Cost Savings with High Performance Provider Network 61921 1Milwaukee Employers See Cost Savings with High Performance Provider Network 61921 2Four Senior Executives Join Orexigen 28R 29 Therapeutics Management Team 61916 1Four Senior Executives Join Orexigen 28R 29 Therapeutics Management Team 61916 2Four Senior Executives Join Orexigen 28R 29 Therapeutics Management Team 61916 3Four Senior Executives Join Orexigen 28R 29 Therapeutics Management Team 61916 4Four Senior Executives Join Orexigen 28R 29 Therapeutics Management Team 61916 5Pearl Therapeutics Appoints Howie Rosen to Board of Directors 14939 1Pearl Therapeutics Appoints Howie Rosen to Board of Directors 14939 2
... and REBETOL(R) will be the only available hepatitis C therapy, approved ... ... approval, KENILWORTH, ... that the Committee for Medicinal,Products for Human Use (CHMP) of the ...
... Sept. 24 Knopp Neurosciences Inc. ("Knopp"),today ... clinical trial of KNS-760704, a,small molecule therapy ... sclerosis (ALS). (Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ... ascending,dose study in healthy volunteers is being ...
Other Medicine Technology:European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 2European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 3European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 4European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 5European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 6European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 7European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy 8Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program 2Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: